In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
May 16th, 2008 | 28 | No |
Popular Name: 1D-Myo-inositol 1,4,5,6-tetrakisphosphate 1D-Myo-inositol 1,4,5,6-tetrakis…
Find On: PubMed — Wikipedia — Google
CAS Numbers: 121010-58-0 , 42932-59-2
1D-myo-inositol 1,4,5,6-tetrakisphosphate(8-)
D-Myo-Inositol 1,4,5,6-tetrakisphosphate; Inositol 1,4,5,6-tetrakisphosphate
D-Myo-Inositol 1,4,5,6-tetrakisphosphate;Inositol 1,4,5,6-tetrakisphosphate
D-myo-Inositol-1,4,5,6-tetraphosphate (sodium salt)
[(1S,2R,3S,4R,5R,6S)-3,4-dihydroxy-2,5,6-tris(phosphonooxy)cyclohexyl]oxyphosphonic acid
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | -5.07 | -9.44 | -485.21 | 5 | 18 | -5 | 322 | 495.032 | 8 | ↓ |
Mid Mid (pH 6-8) | -5.07 | -6 | -1082.13 | 2 | 18 | -8 | 330 | 492.008 | 8 | ↓ |
Mid Mid (pH 6-8) | -5.07 | -7.15 | -877.39 | 3 | 18 | -7 | 327 | 493.016 | 8 | ↓ |
Mid Mid (pH 6-8) | -5.07 | -7.15 | -838.32 | 3 | 18 | -7 | 327 | 493.016 | 8 | ↓ |
Lo Low (pH 4.5-6) | -5.07 | -10.58 | -312.31 | 6 | 18 | -4 | 319 | 496.04 | 8 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Reactome Database Links | REACT_150202; REACT_150284; REACT_150329 | ChEBI |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ITPR3-1-E | Inositol 1,4,5-trisphosphate Receptor Type 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 430 | 0.32 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ITPR3_HUMAN | Q14573 | Inositol 1,4,5-trisphosphate Receptor Type 3, Human | 430 | 0.32 | Binding ≤ 1μM |
ITPR3_HUMAN | Q14573 | Inositol 1,4,5-trisphosphate Receptor Type 3, Human | 430 | 0.32 | Binding ≤ 10μM |
Description | Species |
---|---|
HDACs deacetylate histones | |
IPs transport between ER lumen and nucleus | |
Synthesis of IPs in the ER lumen | |
Synthesis of IPs in the nucleus |
Description | Species |
---|---|
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
Ca2+ pathway | |
DAG and IP3 signaling | |
Effects of PIP2 hydrolysis | |
Elevation of cytosolic Ca2+ levels | |
FCERI mediated Ca+2 mobilization | |
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | |
PLC beta mediated events | |
Regulation of insulin secretion | |
Role of phospholipids in phagocytosis | |
VEGFR2 mediated cell proliferation |